Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARAMIS: Micardis in Isolated Systolic Hypertension
NCT02175355Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1999
- Primary completion
- Aug 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telmisartan in isolated systolic hypertension (ISH), sponsored by Boehringer Ingelheim. Started Oct 1999; status: completed.
02
Drugs
telmisartan
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT02175355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175355.